nVerses Capital’s Dynavax Technologies DVAX Stock Holding History

nVerses Capital’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,149	Closed	-$279K	–	391
2025 Q4	$279K	Buy	+18,149	New	+$200K	0.63%	56
2024 Q2	–	Sell	-7,200	Closed	-$89.4K	–	1052
2024 Q1	$89.4K	Buy	+7,200	New	+$93.9K	0.21%	187

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

nVerses Capital's DVAX Position: Q1 2026 in Review

nVerses Capital sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 18,149 shares — an estimated $279K sold.

nVerses Capital first reported a position in DVAX in Q1 2024 and held it in 2 quarters. The position peaked at $279K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

nVerses Capital reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
nVerses Capital sold 18,149 Dynavax Technologies shares in Q1 2026, an estimated $279K.
nVerses Capital first reported a position in Dynavax Technologies in Q1 2024 and held it in 2 quarters.
nVerses Capital's Dynavax Technologies position peaked at $279K in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.